| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.520 | None | 1.000 | 3 | 0 | 2008 | 2010 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.550 | None | 0.750 | 4 | 0 | 2001 | 2020 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
disease | 0.800 | None | 1.000 | 5 | 0 | 1993 | 2019 | ||||||||
|
arginine vasopressin | 0.437 | 0.846 | 7.4E-02 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2010 | 2011 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.530 | None | 1.000 | 3 | 0 | 2006 | 2013 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.510 | None | 1.000 | 1 | 0 | 2008 | 2009 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.600 | None | 0.800 | 5 | 0 | 2001 | 2019 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
disease | 0.550 | None | 1.000 | 3 | 0 | 2000 | 2019 | ||||||||
|
adrenoceptor alpha 1A | 0.462 | 0.846 | 3.4E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
cAMP responsive element binding protein 1 | 0.463 | 0.885 | 1.00 |
|
disease | 0.510 | None | 1.000 | 1 | 0 | 2001 | 2009 | ||||||||
|
clock circadian regulator | 0.463 | 0.885 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
monoamine oxidase A | 0.465 | 0.769 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
period circadian regulator 2 | 0.488 | 0.846 | 0.71 |
|
disease | 0.320 | None | 0.500 | 2 | 0 | 2006 | 2012 | ||||||||
|
cyclin dependent kinase 5 | 0.495 | 0.846 | 0.14 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
disease | 0.390 | None | 1.000 | 5 | 0 | 2009 | 2019 | ||||||||
|
dopamine receptor D3 | 0.529 | 0.692 | 2.4E-03 |
|
disease | 0.520 | None | 0.667 | 3 | 0 | 1999 | 2010 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
disease | 0.540 | None | 1.000 | 5 | 0 | 2002 | 2014 | ||||||||
|
melanocortin 4 receptor | 0.535 | 0.692 | 9.2E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
tryptophan hydroxylase 2 | 0.546 | 0.654 | 2.5E-07 |
|
disease | 0.320 | None | 0.500 | 2 | 0 | 2006 | 2012 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
disease | 0.500 | None | 1.000 | 2 | 0 | 1998 | 2012 | ||||||||
|
solute carrier family 18 member A2 | 0.554 | 0.769 | 7.6E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
disease | 0.550 | None | 1.000 | 5 | 0 | 1996 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2008 | 2014 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.330 | None | 1.000 | 4 | 0 | 2008 | 2015 |